FMAO(FMAO)
FMAO
$35.77—
NASDAQ
$35.77—
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $137M | $145M |
| Low | $135M | $143M |
| High | $138M | $147M |
| EBITDA Avg | $61M | $62M |
| Low | $57M | $59M |
| High | $63M | $64M |
| EBIT Avg | $55M | $57M |
| Low | $51M | $53M |
| High | $57M | $58M |
| Net Income Avg | $44M | $45M |
| Low | $40M | $42M |
| High | $45M | $46M |
| EPS Avg | $3.17 | $3.27 |
| Low | $2.94 | $3.11 |
| High | $3.31 | $3.37 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $35M | $35M | $36M | $36M | $37M | $37M |
| Low | $34M | $35M | $35M | $36M | $36M | $37M |
| High | $35M | $35M | $36M | $36M | $37M | $37M |
| EBITDA Avg | $16M | $16M | $16M | $16M | $16M | $16M |
| Low | $15M | $15M | $16M | $16M | $16M | $16M |
| High | $16M | $16M | $16M | $16M | $16M | $16M |
| EBIT Avg | $14M | $14M | $14M | $14M | $14M | $14M |
| Low | $14M | $14M | $14M | $14M | $14M | $14M |
| High | $14M | $14M | $14M | $14M | $14M | $14M |
| Net Income Avg | $11M | $11M | $11M | $11M | $11M | $11M |
| Low | $11M | $11M | $11M | $11M | $11M | $11M |
| High | $11M | $11M | $11M | $11M | $11M | $11M |
| EPS Avg | $0.80 | $0.80 | $0.81 | $0.81 | $0.82 | $0.83 |
| Low | $0.79 | $0.79 | $0.80 | $0.81 | $0.82 | $0.82 |
| High | $0.81 | $0.81 | $0.81 | $0.81 | $0.83 | $0.83 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |